Related Experiment Video
Updated: Jan 3, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
The psychopharmacology of brain vascular disease/poststroke depression
Melissa Jones1, Amy Corcoran2, Ricardo E Jorge3
1VA South Central Mental Illness Research, Education and Clinical Center, Houston, TX, United States.
Abstract:
Poststroke depression (PSD) is a frequent complication and source of suffering among stroke survivors. Assessment of mood, suicidal ideation, and other neuropsychiatric disturbances that can co-occur or share similar features with depression are important aspects of clinical stroke care. Pharmacotherapy is the first-line treatment of PSD, with selective serotonin reuptake inhibitors (SSRIs) being agents of first choice. The evidence for SSRIs, newer generation antidepressants, and tricyclic antidepressants for PSD will be reviewed with consideration of their side effect profiles and use for other neuropsychiatric comorbidities. Additional therapeutic options, such as cognitive enhancing medications, brain stimulation, and psychotherapy can also be considered. Given the prevalence of PSD, preventive pharmacologic strategies may be effective alternatives. Ultimately, the choice of treatment will be determined by the type and severity of medical and psychiatric comorbidities as well as the preferences of the patient.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Drug Therapy
Antianxiety Medications
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Antidepressant Drugs: Overview

